Accustem Sciences Inc.
Ticker(s):
ACUT
Country:
Sector & Industry:
Business Overview
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.
Contact & Other Information
Number of Employees:
3
Website:
5 Penn Plaza
19th Floor #1954
New York
,
NY
,
10001
United States
No content was found.